Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.
News-Medical.Net on MSN
Early tuberculosis treatment reduces sepsis deaths in HIV patients
Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...
Blood infection, medically known as sepsis, is one of the leading causes of death, because the body’s response to infection damages tissue and causes organs to fail. Africa has the ...
A new study in "Nature Medicine" estimates 2 million people are incorrectly told they have TB each year — and clinicians miss ...
Patient choice in taking treatment is framed by the physiological and psychological impacts of the disease and also by the social and cultural structures in which the person is immersed. [68] Patient ...
CHARLOTTESVILLE, Va. (WVIR) -A new study led by UVA Health is changing how doctors may treat sepsis in parts of Africa, after ...
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...
Read full article: 2 critically injured in West Side crash; woman arrested, accused of intoxication assault, police say CAPE TOWN – Medical advocacy groups have welcomed Johnson & Johnson’s decision ...
A lingering cough is often blamed on asthma or past tuberculosis, but experts warn that a lesser-known fungal lung disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results